Subdural and Systemic C-Reactive Protein in Patients with Chronic Subdural Hematoma Recurrence
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2026-03 · 53 (2) · 247-253
DOI: 10.1017/cjn.2025.53 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, online erschienen am 28.04.2025. Verfasst von Jonathan Truels Hansen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
C-reactive protein (CRP) level in blood is a standard marker for systemic inflammation. Inflammation is central in chronic subdural hematoma (CSDH) pathophysiology, and inflammatory biomarkers may hold clinical potential in assessing the level of inflammation induced by a CSDH. This study explores the role of CRP in patients with CSDH by (1) measuring systemic and subdural CRP levels, (2) investigating CRP as a potential predictor for recurrent CSDH and (3) comparing CRP levels between the first and second operations in patients with CSDH recurrence.
Methods
CRP levels were measured both in systemic blood and subdural fluid from adult CSDH patients. Recurrence rate and mortality within 90 days were recorded. In total, 111 patients were included, of whom 25 were operated on for CSDH recurrence.
Results
Systemic CRP levels (2.54 mg/L (1.40–9.75)) were higher than subdural levels (2.09 mg/L [0.99–5.22]) ( p < 0.0001) but within the clinically defined normal CRP range of < 3 mg/L. Neither systemic nor subdural CRP levels could predict recurrence. Both systemic and subdural CRP levels in recurrent CSDH patients were higher at the time of the second surgery compared to the first surgery ( p systemic = 0.004 and p subdural < 0.0001).
Conclusion
This is the first study to establish a correlation between systemic and subdural CRP levels in CSDH patients. The increased levels of CRP at the time of the second surgery may demonstrate a constantly evolving inflammatory process toward the development of a recurrence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Internal Medicine, University Hospital - Holbaek, Holbaek, Denmark.
- Department of Neuroanesthesiology, The Neuroscience Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Anaesthesiology, Zealand University Hospital, Køge, Denmark.
- Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Rigshospitalet & Department of Biomedical Sciences, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Jonathan Truels Hansen
Zitieren
APA
Hansen, J. T., Tursø, T. S. V., Olsen, M. H., Binderup, T., Fugleholm, K., & Jensen, T. S. R. (2026). Subdural and Systemic C-Reactive Protein in Patients with Chronic Subdural Hematoma Recurrence. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 53(2), 247-253. https://doi.org/10.1017/cjn.2025.53
Vancouver
Hansen JT, Tursø TSV, Olsen MH, Binderup T, Fugleholm K, Jensen TSR. Subdural and Systemic C-Reactive Protein in Patients with Chronic Subdural Hematoma Recurrence. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2026;53(2):247-253. doi:10.1017/cjn.2025.53
BibTeX
@article{Hansen2026,
author = {Hansen, Jonathan Truels and Tursø, Thomas Svinning Valeur and Olsen, Markus Harboe and Binderup, Tina and Fugleholm, Kåre and Jensen, Thorbjørn Søren Rønn},
title = {Subdural and Systemic C-Reactive Protein in Patients with Chronic Subdural Hematoma Recurrence},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2026},
volume = {53},
number = {2},
pages = {247--253},
doi = {10.1017/cjn.2025.53}
}
EUVIMED